Richard Scheife
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Urology top 5%
- Urinary Bladder and Prostate Research
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 3
- Amyotrophic Lateral Sclerosis Research 2
- Neurological disorders and treatments 2
- Co-authors
- Masayuki Takeda (1 shared paper)Michael Barza (1 shared paper)Mildred D. Gottwald (1 shared paper)Glen T. Schumock (1 shared paper)Mark S. Luer (1 shared paper)Aaron H. Burstein (1 shared paper)Jesús S. Mora (2 shared papers)Michael Wittie (1 shared paper)
- Journals
- American Journal of Health-System Pharmacy (5 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Neurology (2 papers)American Journal of Pharmaceutical Education (1 paper)Clinical Neuropharmacology (1 paper)
- Partner nations
- United StatesNew ZealandJapan
In The Last Decade
Richard Scheife
20 papers receiving 569 citations
Peers
Comparison fields: 5 of 125
- Geriatrics and Gerontology 80
- Urology 75
- Toxicology 32
- Family Practice 19
- Neurology 111
Countries citing papers authored by Richard Scheife
This map shows the geographic impact of Richard Scheife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Scheife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Scheife more than expected).
Fields of papers citing papers by Richard Scheife
This network shows the impact of papers produced by Richard Scheife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Scheife. The network helps show where Richard Scheife may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Scheife, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 119 | |
| 2 | 2015 | 101 | |
| 3 | 2000 | 51 | |
| 4 | 1989 | 47 | |
| 5 | 2012 | 46 | |
| 6 | 1977 | 46 | |
| 7 | 1993 | 39 | |
| 8 | 1984 | 31 | |
| 9 | 1976 | 25 | |
| 10 | 2009 | 23 | |
| 11 | 1986 | 23 | |
| 12 | 1990 | 18 | |
| 13 | 1977 | 11 | |
| 14 | 1982 | 7 | |
| 15 | 1981 | 5 | |
| 16 | 1981 | 5 | |
| 17 | 1979 | 2 | |
| 18 | 1988 | 1 | |
| 19 | 1982 | 1 | |
| 20 | 2000 | 1 |
About Richard Scheife
Richard Scheife is a scholar working on Neurology, Infectious Diseases, Pharmacology, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 21 papers that have together received 602 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (3 papers), Pharmaceutical studies and practices (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Neurological disorders and treatments (2 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Geriatrics and Gerontology (80 citations), Urology (75 citations), Toxicology (32 citations), Family Practice (19 citations) and Neurology (111 citations). Richard Scheife has collaborated with scholars based in United States, New Zealand and Japan. Frequent co-authors include Masayuki Takeda, Michael Barza, Mildred D. Gottwald, Glen T. Schumock, Mark S. Luer, Aaron H. Burstein, Jesús S. Mora, Michael Wittie, Nicholas M. P. King and Mary Brown. Their work appears in journals such as American Journal of Health-System Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Neurology, American Journal of Pharmaceutical Education and Clinical Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.